Europe In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Services), By Technique (Immunology, Hematology, Clinical Chemistry, Coagulation, Microbiology, Molecular Diagnostics) By Application By End-use, And Segment Forecasts To 2024

Methodology

We implement a mix of primary and secondary research for our market estimate and forecast. Secondary research forms the initial phase of our study, where we conduct extensive data mining, referring to verified data sources such as independent studies, government and regulatory published material, technical journals, trade magazines, and paid data sources such as IMS Health and so on. This forms the basis of our estimates. For forecasting, the following parameters are considered:

• Market drivers and restraints, along with their current and expected impacts
• Regulatory scenario and expected developments
• Disease prevalence and incidence trends and demographic trends

We assign weights to these parameters and quantify their market impact using weighted average analysis, to derive an expected market growth rate. Further, we use correlation, regression, and time-series analysis to evaluate key industry dynamics. All our estimates and forecasts are verified through exhaustive primary research with Key Industry Participants (KIPs), which typically include:

• Market leading participants
• Product distributors and vendors
• Key consumers and clients

These exhaustive primary interviews help our analysts in validating market and segment estimates and forecast. Additionally, we also gain significant industry insights, key developments, and expectations. Grand View Research only utilizes validated and authenticated secondary data sources.

Data Collection Matrix

Industry Analysis Matrix